CEO Martin Lehr featured in Life Science Leader Magazine
Context Therapeutics Signs Strategic Research Collaborations for Apristor® with Leading Breast Cancer Investigators
My Life As A Recovering VC, Zigging Where Others Zag
CEO Martin Lehr Named Ernst & Young 2018 Entrepreneur of the Year Semifinalist
PHILADELPHIA, PA--(BUSINESS WIRE)— Context Therapeutics, a clinical stage biopharmaceutical company dedicated to the treatment of hormone driven cancers, today announces it has signed multiple research collaborations to further understand the role of progesterone receptor (PR) signaling and its blockade to overcome resistance mechanisms underlying metastatic breast cancer (mBCa).
PHILADELPHIA, Pa.--(BUSINESS WIRE)—Context Therapeutics, a clinical-stage biopharmaceutical company focused on hormonally-driven cancers, announced that CEO Martin Lehr is a semifinalist for Ernst, & Young’s (EY) 2018 Entrepreneur of the Year for the Philadelphia region.